DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / E• H••••••••• P•••••••
E• H••••••••• P•••••••
Private equity with venture activity · probableThe Woodlands, TXe•••••••••.comSEC registered investment adviser
As a healthcare growth equity firm, we empower companies in the US and Europe to drive positive change in healthcare while delivering high returns.
registered adviser; venture funds are 23% of 19 private funds
Importance
39
elevated
Active deployment
30
moderate
Emerging
0
low
Completeness
81
high
Freshness
99
high
Research priority
11
low
Identity and regulatory footprint
- Headquarters
- The Woodlands, TXadviserinfo.sec.gov
- Office address
- 21 WATERWAY AVENUE, SUITE 150, The Woodlands, TX, 77380-3099adviserinfo.sec.gov
- Business phone
- 281-364-1555adviserinfo.sec.gov
- Website
- e•••••••••.com
- SEC adviser type
- registered investment adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- May 12, 2026
- Private funds reported
- 19 (6 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $2.5Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $2.1Bthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 13
- business email
- houston@ewhealthcare.comewhealthcare.compublished by the subject
- business email
- newyork@ewhealthcare.comewhealthcare.compublished by the subject
- business phone
- 281-364-1555adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
28 observed deals
Stated (the firm’s website)
- Sectors
- healthcare, biotech, medtech, space, industrial
- Stages
- growth
- Geography
- new york, uk
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- growth investor
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 93%Other Health Care 7%
lead rate n/afollow-on rate n/anew logos, 12 months 28
Funds and vehicles
7 reported, 1 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| E• F••• I• S••• L• | SPV or co-invest vehicle | 2019 adv first reported | Mature | $21.7M Oct 7, 2024 | 2 | unknown | unknown |
| E• F••• V• S••• L• | SPV or co-invest vehicle | 2019 adv first reported | Mature | $5.9M Oct 7, 2024 | 2 | unknown | unknown |
| E•••• W•••••••• H••••• V••••••• F••• V••• | Fund | 2008 lp reported | Harvest | unknown | unknown | unknown | unknown |
| E•••• W•••••••• H••••• V••••••• F••• V•• L• | Fund | unknown | Unknown | $81.9M Oct 7, 2024 | 31 | unknown | unknown |
| E•••• W•••••••• H••••• V••••••• F••• I•• L• | Fund | unknown | Unknown | $33.4M Oct 7, 2024 | 23 | unknown | unknown |
| E•••• W•••••••• H••••• V••••••• F••• V••• L••• | Fund | unknown | Unknown | $8.1M Oct 7, 2024 | 26 | unknown | unknown |
| E•••• W•••••••• H••••• V••••••• F••• V• L• | Fund | unknown | Unknown | $7.3M Oct 7, 2024 | 36 | unknown | unknown |
| E•••• W•••••••• H••••• V••••••• F••• I••• L• | Fund | unknown | Wound down | $1.6M Jan 2, 2021 | 24 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
21 current, 5 departed
P••• C•••••••••
AssociateAssociate
B••• H••••••
Board or advisorySenior Advisor
R•• E••••••
Board or advisorySenior Advisor
Founder or executive
P•••• V•••••
Founder or executiveExecutive Chairman
M•••• S•••••
Managing partnerFounding Partner
B•• W••••
Operating partnerOperating Partner
B•••• M•••••
Operating partnerOperating Partner
G•••• N••••
Operating partnerOperating Partner
B••••• A••••••
PartnerManaging Director
I••••••• N•• T••••••••
PartnerManaging Director · since Nov 1, 2003
J••• S••••• H••••••
PartnerManaging Director · since Nov 1, 2003
M••••• P••• S•••••
PartnerPresident, Director, Secretary, Managing Director · since Nov 1, 2003
P•••• T••••• V•••••
PartnerTreasurer, Director, Managing Director · since Nov 1, 2003
G••• H•••
Platform and operationsChief Financial Officer / Chief Compliance Officer
G•••••• L•• H•••
Platform and operationsCco, Cfo · since Aug 1, 2023
R•••••• L•• K•••••••••
Platform and operationsCfo - Legacy Funds · since Nov 1, 2003
S•••• B••••
Platform and operationsCOO
F•••••• T••••••
PrincipalSenior Principal
R••• C•••••
PrincipalPrincipal
J••••••• R••••
Vice presidentVice President
5 departed (kept with end dates)
- G•••• J••••• N•••• · Managing Director · Nov 1, 2003 to Mar 29, 2024 Inference
- J•••• L••• C••••• · Managing Director · Nov 1, 2003 to Mar 31, 2017 Inference
- R•• W•••••• E•••••• · Managing Director · Nov 1, 2003 to Mar 29, 2024 Inference
- S•••• B•••• · Managing Director · Nov 1, 2012 to Mar 29, 2024 Inference
- S•••••• F••• W•••••• · Managing Director · Nov 1, 2003 to Mar 29, 2024 Inference
Investments on record
28 edges, 28 companies, 0 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
10 relationships from shared deals, counted for the whole firm
Boston Millennia Partners 1 shared · one timeNyca Management LLC 1 shared · one timeFJ Labs 1 shared · one timeFirstmark Capital, LLC 1 shared · one timeDistributed Ventures 1 shared · one timeInterplay Ventures Early Stage Management LLC 1 shared · one timeAperture Management LLC 1 shared · one timeCamden Partners Growth Equity 1 shared · one time1315 Capital 1 shared · one timeIndex Ventures Sa 1 shared · one time
Limited partners
9 disclosed
- W••••••••• S•••• I••••••••• B•••• in E•••• W•••••••• H••••• V••••••• F••• V• L• $25.0M sib.wa.gov
- W••••••••• S•••• I••••••••• B•••• in E•••• W•••••••• H••••• V••••••• F••• V•• L• $25.0M sib.wa.gov
- O••••• P••••• E•••••••• R••••••••• F••• in E•••• W•••••••• H••••• V••••••• F••• V•• L• $25.0M oregon.gov
- O••••• P••••• E•••••••• R••••••••• F••• in E•••• W•••••••• H••••• V••••••• F••• V••• $100M oregon.gov
- O••••• P••••• E•••••••• R••••••••• F••• in E•••• W•••••••• H••••• V••••••• F••• V••• L••• $50.0M oregon.gov
- M••••••••• P•••••• R••••••• I••••••••• M••••••••• B•••• amount undisclosed mapension.com
- L•• A•••••• C••• E••••••••• R••••••••• S••••• in E•••• W•••••••• H••••• V••••••• F••• V• L• $10.0M lacers.org
- L•• A•••••• C••• E••••••••• R••••••••• S••••• in E•••• W•••••••• H••••• V••••••• F••• V•• L• $15.0M lacers.org
- L•• A•••••• C••• E••••••••• R••••••••• S••••• in E•••• W•••••••• H••••• V••••••• F••• I•• L• $4.0M lacers.org
Timeline
17 dated events
- Jun 30, 2025Mass PRIM lists E•••• W•••••••• H••••• Ventures among its private equity managers
- Mar 29, 2024R•••••• S•••• B•••• (Managing Director) no longer on Schedule A of E• H••••••••• P•••••••
- Mar 29, 2024S•••••• F••• W•••••• (Managing Director) no longer on Schedule A of E• H••••••••• P•••••••
- Mar 29, 2024R•• W•••••• E•••••• (Managing Director) no longer on Schedule A of E• H••••••••• P•••••••
- Mar 29, 2024G•••• J••••• N•••• (Managing Director) no longer on Schedule A of E• H••••••••• P•••••••
- Aug 1, 2023G•••••• L•• H••• joined Schedule A of E• H••••••••• P••••••• as Cco, Cfo
- Mar 31, 2021E•••• W•••••••• H••••• V••••••• F••• I••• L• no longer reported on Form ADV by E• H••••••••• P•••••••Fund no longer reportedFundsInferenceE•••• W•••••••• H••••• V••••••• F••• I••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2019E• F••• I• S••• L• first reported on Form ADV by E• H••••••••• P••••••• (Venture Capital Fund), GAV $30,192,348Fund first reported on Form ADVFundsFactE• F••• I• S••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2019E• F••• V• S••• L• first reported on Form ADV by E• H••••••••• P••••••• (Venture Capital Fund), GAV $159,383,225Fund first reported on Form ADVFundsFactE• F••• V• S••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2017J•••• L••• C••••• (Managing Director) no longer on Schedule A of E•••• W•••••••• Management, Inc.
- Nov 1, 2012S•••• B•••• joined Schedule A of E•••• W•••••••• Management, Inc. as Managing Director
- Feb 14, 2012E•••• W•••••••• H••••• V••••••• F••• V•• L• first reported on Form ADV by E•••• W•••••••• (Venture Capital Fund), GAV $272,081,919Fund first reported on Form ADVFundsFactE•••• W•••••••• H••••• V••••••• F••• V•• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2012E•••• W•••••••• H••••• V••••••• F••• V• L• first reported on Form ADV by E•••• W•••••••• (Venture Capital Fund), GAV $150,754,166Fund first reported on Form ADVFundsFactE•••• W•••••••• H••••• V••••••• F••• V• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2012E•••• W•••••••• H••••• V••••••• F••• I•• L• first reported on Form ADV by E•••• W•••••••• (Venture Capital Fund), GAV $26,010,250Fund first reported on Form ADVFundsFactE•••• W•••••••• H••••• V••••••• F••• I•• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2012E•••• W•••••••• H••••• V••••••• F••• I••• L• first reported on Form ADV by E•••• W•••••••• (Venture Capital Fund), GAV $7,976,686Fund first reported on Form ADVFundsFactE•••• W•••••••• H••••• V••••••• F••• I••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2012E•••• W•••••••• first filed Form ADV (IA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2012E•••• W•••••••• H••••• Ventures Fund VII, LP first reported on Form ADV by E•••• W•••••••• (Private Equity Fund), GAV $472,586,601Fund first reported on Form ADVFundsFactE•••• W•••••••• H••••• V••••••• F••• V••• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 23% of 19 private funds
- Sep 12, 2026Private equity with venture activity (probable, 75%, cls-1)registered adviser; venture funds are 23% of 22 private funds
Evidence
68 observations from 3 sources